Knock-Out Finder
Your selection:
76 Results
| FC0L37 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 39.008 | 39.008 | 2.876 | 33.205% | - | Société Générale | ||
| FC6P8W | Biomarin Pharmaceutical Inc./KO/Put [endlos]/SOC | - | - | put | Biomarin Pharmaceutical Inc. | 61.084 | 61.084 | 15.060 | 4.597% | - | Société Générale | ||
| FC9LWW | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 54.444 | 54.444 | 10.346 | 6.774% | - | Société Générale | ||
| FD1P8L | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 35.880 | 40.200 | 2.540 | 31.164% | - | Société Générale | ||
| FE5W9E | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 41.212 | 46.170 | 3.368 | 20.942% | - | Société Générale | ||
| FG07TY | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 47.912 | 53.380 | 5.280 | 8.596% | - | Société Générale | ||
| FG0DU0 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 48.399 | 48.399 | 5.237 | 17.125% | - | Société Générale | ||
| FG0DU1 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 50.414 | 50.414 | 6.336 | 13.675% | - | Société Générale | ||
| FG0DU2 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 52.429 | 52.429 | 8.014 | 10.225% | - | Société Générale | ||
| FG0DUZ | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 46.384 | 46.384 | 4.421 | 20.575% | - | Société Générale | ||
| FG0W62 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 56.439 | 56.439 | 17.107 | 3.357% | - | Société Générale | ||
| FG1RYU | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 58.432 | 58.432 | - | -0.055% | - | Société Générale | ||
| FG1VX1 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 49.586 | 55.380 | 6.040 | 5.171% | - | Société Générale | ||
| GG0DRZ | Biomarin Pharmaceutical Inc./Faktor/Short [5]/GOLDS | - | - | put | Biomarin Pharmaceutical Inc. | 65.352 | 62.763 | 4.708 | 7.470% | - | Goldman Sachs | ||
| GG4VK6 | Biomarin Pharmaceutical Inc./Faktor/Long [2]/GOLDS | - | - | call | Biomarin Pharmaceutical Inc. | 27.230 | 50.329 | 1.987 | 13.821% | - | Goldman Sachs | ||
| GK8V7F | Biomarin Pharmaceutical Inc./Faktor/Short [2]/GOLDS | - | - | put | Biomarin Pharmaceutical Inc. | 81.690 | 68.092 | 1.963 | 16.595% | - | Goldman Sachs | ||
| GU8SM5 | Biomarin Pharmaceutical Inc./Faktor/Long [10]/GOLDS | - | - | call | Biomarin Pharmaceutical Inc. | 53.289 | 57.434 | 6.403 | 1.655% | - | Goldman Sachs | ||
| GU8WZL | Biomarin Pharmaceutical Inc./Faktor/Long [4]/GOLDS | - | - | call | Biomarin Pharmaceutical Inc. | 44.408 | 54.769 | 3.998 | 6.217% | - | Goldman Sachs | ||
| GU8X1H | Biomarin Pharmaceutical Inc./Faktor/Short [10]/GOLDS | - | - | put | Biomarin Pharmaceutical Inc. | 65.131 | 60.986 | 6.399 | 4.429% | - | Goldman Sachs | ||
| GV6L9A | Biomarin Pharmaceutical Inc./Faktor/Long [5]/GOLDS | - | - | call | Biomarin Pharmaceutical Inc. | 43.568 | 55.657 | 5.021 | 4.696% | - | Goldman Sachs | ||
| GW1DM7 | Biomarin Pharmaceutical Inc./Faktor/Short [4]/GOLDS | - | - | put | Biomarin Pharmaceutical Inc. | 74.013 | 63.651 | 3.845 | 8.991% | - | Goldman Sachs | ||
| GW1GEZ | Biomarin Pharmaceutical Inc./Faktor/Short [3]/GOLDS | - | - | put | Biomarin Pharmaceutical Inc. | 78.947 | 65.131 | - | 11.526% | - | Goldman Sachs | ||
| GW6MFU | Biomarin Pharmaceutical Inc./Faktor/Long [3]/GOLDS | - | - | call | Biomarin Pharmaceutical Inc. | 39.473 | 53.289 | - | 8.752% | - | Goldman Sachs | ||
| GW6ZHR | Biomarin Pharmaceutical Inc./Faktor/Long [15]/GOLDS | - | - | call | Biomarin Pharmaceutical Inc. | 55.263 | 58.026 | - | 0.641% | - | Goldman Sachs | ||
| GW7BXW | Biomarin Pharmaceutical Inc./Faktor/Short [15]/GOLDS | - | - | put | Biomarin Pharmaceutical Inc. | 63.157 | 60.394 | - | 3.415% | - | Goldman Sachs | ||
| LX9Q43 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 30.040 | 30.040 | 2.154 | 41.396% | - | Lang & Schwarz | ||
| LX9Q44 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 32.043 | 32.043 | 2.330 | 37.489% | - | Lang & Schwarz | ||
| LX9Q45 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 34.046 | 34.046 | 2.563 | 33.583% | - | Lang & Schwarz | ||
| LX9Q46 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 36.048 | 36.048 | 2.832 | 29.676% | - | Lang & Schwarz | ||
| LX9Q47 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 38.051 | 38.051 | 3.145 | 25.769% | - | Lang & Schwarz | ||
| LX9Q48 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 40.054 | 40.054 | 3.511 | 21.862% | - | Lang & Schwarz | ||
| LX9Q49 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 42.056 | 42.056 | 4.068 | 17.955% | - | Lang & Schwarz | ||
| LX9Q5A | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 44.059 | 44.059 | 4.703 | 14.048% | - | Lang & Schwarz | ||
| LX9Q5B | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 46.062 | 46.062 | 5.633 | 10.141% | - | Lang & Schwarz | ||
| LX9Q5C | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 48.064 | 48.064 | 7.220 | 6.234% | - | Lang & Schwarz | ||
| LX9Q5D | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 50.067 | 50.067 | 9.858 | 2.327% | - | Lang & Schwarz | ||
| LX9Q61 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 48.055 | 48.055 | 7.032 | 6.252% | - | Lang & Schwarz | ||
| LX9Q6V | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 36.041 | 36.041 | 2.795 | 29.689% | - | Lang & Schwarz | ||
| LX9Q6X | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 40.046 | 40.046 | 3.430 | 21.877% | - | Lang & Schwarz | ||
| LX9Q6Z | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 44.051 | 44.051 | 4.673 | 14.064% | - | Lang & Schwarz | ||
| LX9SD0 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 52.000 | 52.000 | - | -1.444% | - | Lang & Schwarz | ||
| LX9SHK | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 52.000 | 52.000 | - | -1.444% | - | Lang & Schwarz | ||
| LX9STW | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 52.000 | 52.000 | - | -1.444% | - | Lang & Schwarz | ||
| LX9SYJ | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 52.000 | 52.000 | - | -1.444% | - | Lang & Schwarz | ||
| MG69UR |  | Biomarin Pharmaceutical Inc./KO/Call [endlos]/MS | - | - | call | Biomarin Pharmaceutical Inc. | 44.608 | 48.170 | 4.041 | 17.517% | - | Morgan Stanley | |
| MJ1B3S | | Biomarin Pharmaceutical Inc./KO/Put [endlos]/MS | - | - | put | Biomarin Pharmaceutical Inc. | 79.455 | 79.455 | 2.847 | 36.053% | - | Morgan Stanley | |
| MJ1BZ9 | | Biomarin Pharmaceutical Inc./Faktor/Long [4]/MS | - | - | call | Biomarin Pharmaceutical Inc. | 44.418 | 44.418 | 3.999 | 23.943% | - | Morgan Stanley | |
| MJ27ZH | | Biomarin Pharmaceutical Inc./KO/Put [endlos]/MS | - | - | put | Biomarin Pharmaceutical Inc. | 80.953 | 74.470 | 2.573 | 27.517% | - | Morgan Stanley | |
| MJ5AYN | | Biomarin Pharmaceutical Inc./KO/Call [endlos]/MS | - | - | call | Biomarin Pharmaceutical Inc. | 46.233 | 46.233 | - | 20.834% | - | Morgan Stanley | |
| MK4BHP | | Biomarin Pharmaceutical Inc./Faktor/Long [3]/MS | - | - | call | Biomarin Pharmaceutical Inc. | 39.482 | 39.482 | 3.003 | 32.393% | - | Morgan Stanley |